Statistical analyses were performed using R. <b>Results:</b><i>TIMP1</i> was the only inhibitor overexpressed in breast tumors and showed significant associations with the Luminal B, HER2, TNBC, and normal-like subtypes, along with a modest increase across stages. Here, ERBB2 is linked to breast neoplasm.